Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Patent
1993-04-19
1996-11-05
Wax, Robert A.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
424 9463, 4241921, 435 71, 4351885, 435212, 435214, 435217, 5303873, 536 221, 536 231, 536 232, 536 234, 536 2353, C12P 2108, A61K 3848, C07K 1600, C07H 1900
Patent
active
055717080
ABSTRACT:
A new chimeric plasminogen activator with high fibrin affinity was designed to bind to a fibrin clot and initiate clot destruction in the presence of thrombin, but not plasmin. The chimeric molecule has an antibody variable region having a fibrin-specific antigen binding site and a single chain urokinase region having a thrombin activation site but not a plasmin activation site. The preferred embodiment, 59D8-ScuPA-T, has an N-terminal fragment of an anti-fibrin antibody (59DB) and a C-terminal thrombin-activatable low molecular weight single-chain urokinase plasminogen activator (scuPA-T). The scuPA-T portion was obtained by deletion of two amino acids (Phe157 and Lys 158) that make up the plasmin activation site from low molecular weight single chain urokinase-type plasminogen activator (scuPA).
Matsueda Gary R.
Shaw Shyh-Yu
Yang Wen-Pin
Bristol--Myers Squibb Company
Gaul Timothy J.
Kim Hyosuk
Savitsky Thomas R.
Wax Robert A.
LandOfFree
Thrombin-activatable plasminogen activator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin-activatable plasminogen activator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin-activatable plasminogen activator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2014409